Mauro is a member of the Bird & Bird international life sciences and intellectual property group. He has more than 15 years' experience advising clients on life sciences (medicinal products, medical devices, food supplements, cosmetics, plant protection products etc.) mainly in relation to regulatory and intellectual property issues such as: classifications issues, R&D and clinical trial issues, authorisation/registration/certification procedure, RDP issues, market access including early access programmes and price and reimbursement issues, pharmacovigilance/materio-vigilance, compliance (including advertising and interaction with HCPs, HCO, patient and scientific associations), relevant commercial agreements. Mauro spent several years working for several medicines authorities: the Italian Ministry of Health and then the Italian Medicines Agency (AIFA) as well as the European Medicines Agency (EMA). He provided legal support to the Paediatric Committee (PDCO) and the Name Review Group (NRG) and also contributed to the Advanced Therapy Regulation implementation. While there, Mauro was responsible for providing a full range of pharmaceuticals advice, including generics and data exclusivity issues, biosimilars, parallel import and parallel distribution issues, orphan drugs, SMEs and transparency issues. Mauro was also a member of the EMA Innovation Task Force (ITF), which is the team specialised in product classification and borderline issues. Since 2015 Mauro has been listed by Who’s Who Legal among the Italian life sciences regulatory experts. In 2018, following nominations from clients, Mauro was awarded the ILO Client Choice Award for "Best Healthcare & Life Sciences lawyer – Italy".